Saturday, 21 April 2018 - 16:33
  • it
  • de
  • en
  • fr

Prevenar 13

Pfizer: India grants patent protection to Prevenar 13

The Indian regulatory authority granted Pfizer exclusive patent protection for its vaccine Prevenar 13 until 2026. The decision prevents other companies from producing cheaper copies of the drug. The news is strategically significant, since India is the country with the…

China, green light for Pfizer’s Prevenar 13

The China Food and Drug Administration has approved Pfizer’s blockbuster vaccine Prevenar 13. This is definitely a breakthrough for the US giant, being the vaccine one of the top products in the company’s portfolio. Prevenar 13 is used primarily for…